Approvals/TGA/BENEFIX factor IX recombinant 250 IU powder for injection vial and diluent syringe composite pack

Approved

STANDARD

BENEFIX factor IX recombinant 250 IU powder for injection vial and diluent syringe composite pack

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 6c87c3230080f826
Product Name: BENEFIX factor IX recombinant 250 IU powder for injection vial and diluent syringe composite pack
Artg Id: 128339
Artg Name: BENEFIX factor IX recombinant 250IU powder for injection vial and diluent syringe composite pack
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2007-09-27
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/28ed7b175a23eb3bf56e005f043926a0.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/6a7637ed1adada34f922923c2f8238eb.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

6c87c3230080f826

Type

Standard